Neurosterix
Advanced allosteric modulator therapeutics developer for neurological disorders.
1
Funding Rounds
$63.0m
Money raised
Overview
Advanced allosteric modulator therapeutics developer for neurological disorders.
- Website:
- Headquarters: Geneva
Funding series
Funding Series Analysis
The company Neurosterix has raised a total of $63m in funding over 1 rounds.
Key Insights:
- Neurosterix April 2024 Series A Funding Round: $63m
Neurosterix April 2024 Series A Funding Round
$63m